Assessing the impact of pharmacist led weight loss surgery medication evaluation
Journal of the American Pharmacists Association · 2026-07 · 66 (4) · 103114
DOI: 10.1016/j.japh.2026.103114 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Pharmacists Association, 2026-07. Verfasst von Jubilee Winar und 3 weiteren Autor:innen. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND Weight loss surgery (WLS) can lead to nutrient deficiencies and altered medication absorption and distribution. Optimizing medication management, including dose changes, initiation, or discontinuation of medications, addressing medication adherence, and patient education, is crucial for positive outcomes. OBJECTIVES The primary objective of this initiative was to evaluate the impact of a single pre-WLS pharmacist-led medication reconciliation and education visit on medication adherence, measured by self-reported missed doses over the preceding seven days. The secondary outcome was an assessment of provider acceptance of pharmacist-driven medication recommendations during routine clinical care. PRACTICE DESCRIPTION MetroHealth System, a large public academic safety net hospital serving a predominantly under- or uninsured population in Northeast Ohio. Wherein WLS patients have appointments with a weight management provider, surgeon, behavioral health specialist, and registered dietician. PRACTICE INNOVATION The current health care team caring for patients undergoing WLS does not include a clinical pharmacist. The pharmacist reviewed medication regimens pre- and post-WLS, assessed for patient adherence, provided patient education, and made recommendations to the WLS care team to ensure safe and effective medication use. EVALUATION METHODS Medication adherence changes, adherence barriers, and acceptance of pharmacist recommendations were evaluated and reported using descriptive statistics. RESULTS This initiative found a statistically significant decrease in medication adherence. The average number of missed doses per week increased significantly from baseline (0.06) to follow-up (1.15) (p=0.001). Providers accepted at least one pharmacist recommendation for 28 out of 49 patients (57.1%). CONCLUSION This initiative demonstrates the value of pharmacist involvement in WLS care. Medication adherence remained high, and the strong acceptance of pharmacist recommendations supports the benefit of pharmacist led medication review. The minor decline in follow up adherence may reflect reduced post-WLS motivation. Controlled studies are needed to more clearly define the impact of pharmacist services.
Zitieren
APA
Winar, J., Doycich, E., Bardaro, S., & Gothard, D. (2026). Assessing the impact of pharmacist led weight loss surgery medication evaluation. Journal of the American Pharmacists Association, 66(4), 103114. https://doi.org/10.1016/j.japh.2026.103114
Vancouver
Winar J, Doycich E, Bardaro S, Gothard D. Assessing the impact of pharmacist led weight loss surgery medication evaluation. Journal of the American Pharmacists Association. 2026;66(4):103114. doi:10.1016/j.japh.2026.103114
BibTeX
@article{Winar2026,
author = {Winar, Jubilee and Doycich, Emily and Bardaro, Sergio and Gothard, Dave},
title = {Assessing the impact of pharmacist led weight loss surgery medication evaluation},
journal = {Journal of the American Pharmacists Association},
year = {2026},
volume = {66},
number = {4},
pages = {103114},
doi = {10.1016/j.japh.2026.103114}
}
EUVIMED